These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26869068)

  • 1. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD.
    Boeynaems S; Bogaert E; Michiels E; Gijselinck I; Sieben A; Jovičić A; De Baets G; Scheveneels W; Steyaert J; Cuijt I; Verstrepen KJ; Callaerts P; Rousseau F; Schymkowitz J; Cruts M; Van Broeckhoven C; Van Damme P; Gitler AD; Robberecht W; Van Den Bosch L
    Sci Rep; 2016 Feb; 6():20877. PubMed ID: 26869068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.
    McEachin ZT; Gendron TF; Raj N; García-Murias M; Banerjee A; Purcell RH; Ward PJ; Todd TW; Merritt-Garza ME; Jansen-West K; Hales CM; García-Sobrino T; Quintáns B; Holler CJ; Taylor G; San Millán B; Teijeira S; Yamashita T; Ohkubo R; Boulis NM; Xu C; Wen Z; Streichenberger N; ; Fogel BL; Kukar T; Abe K; Dickson DW; Arias M; Glass JD; Jiang J; Tansey MG; Sobrido MJ; Petrucelli L; Rossoll W; Bassell GJ
    Neuron; 2020 Jul; 107(2):292-305.e6. PubMed ID: 32375063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.
    Jovičić A; Mertens J; Boeynaems S; Bogaert E; Chai N; Yamada SB; Paul JW; Sun S; Herdy JR; Bieri G; Kramer NJ; Gage FH; Van Den Bosch L; Robberecht W; Gitler AD
    Nat Neurosci; 2015 Sep; 18(9):1226-9. PubMed ID: 26308983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
    Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
    EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
    Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
    Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD.
    Westergard T; Jensen BK; Wen X; Cai J; Kropf E; Iacovitti L; Pasinelli P; Trotti D
    Cell Rep; 2016 Oct; 17(3):645-652. PubMed ID: 27732842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carboxyl termini of RAN translated GGGGCC nucleotide repeat expansions modulate toxicity in models of ALS/FTD.
    He F; Flores BN; Krans A; Frazer M; Natla S; Niraula S; Adefioye O; Barmada SJ; Todd PK
    Acta Neuropathol Commun; 2020 Aug; 8(1):122. PubMed ID: 32753055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport.
    Freibaum BD; Lu Y; Lopez-Gonzalez R; Kim NC; Almeida S; Lee KH; Badders N; Valentine M; Miller BL; Wong PC; Petrucelli L; Kim HJ; Gao FB; Taylor JP
    Nature; 2015 Sep; 525(7567):129-33. PubMed ID: 26308899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity.
    Kramer NJ; Haney MS; Morgens DW; Jovičić A; Couthouis J; Li A; Ousey J; Ma R; Bieri G; Tsui CK; Shi Y; Hertz NT; Tessier-Lavigne M; Ichida JK; Bassik MC; Gitler AD
    Nat Genet; 2018 Apr; 50(4):603-612. PubMed ID: 29507424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles.
    Lee KH; Zhang P; Kim HJ; Mitrea DM; Sarkar M; Freibaum BD; Cika J; Coughlin M; Messing J; Molliex A; Maxwell BA; Kim NC; Temirov J; Moore J; Kolaitis RM; Shaw TI; Bai B; Peng J; Kriwacki RW; Taylor JP
    Cell; 2016 Oct; 167(3):774-788.e17. PubMed ID: 27768896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell-penetrant peptide blocking
    Castelli LM; Lin YH; Sanchez-Martinez A; Gül A; Mohd Imran K; Higginbottom A; Upadhyay SK; Márkus NM; Rua Martins R; Cooper-Knock J; Montmasson C; Cohen R; Walton A; Bauer CS; De Vos KJ; Mead RJ; Azzouz M; Dominguez C; Ferraiuolo L; Shaw PJ; Whitworth AJ; Hautbergue GM
    Sci Transl Med; 2023 Mar; 15(685):eabo3823. PubMed ID: 36857431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.
    Odeh HM; Shorter J
    Emerg Top Life Sci; 2020 Dec; 4(3):293-305. PubMed ID: 32639008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in
    Xu W; Xu J
    J Neurosci; 2018 Aug; 38(35):7741-7752. PubMed ID: 30037833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) promotes toxicity of
    Gao J; Mewborne QT; Girdhar A; Sheth U; Coyne AN; Punathil R; Kang BG; Dasovich M; Veire A; DeJesus Hernandez M; Liu S; Shi Z; Dafinca R; Fouquerel E; Talbot K; Kam TI; Zhang YJ; Dickson D; Petrucelli L; van Blitterswijk M; Guo L; Dawson TM; Dawson VL; Leung AKL; Lloyd TE; Gendron TF; Rothstein JD; Zhang K
    Sci Transl Med; 2022 Sep; 14(662):eabq3215. PubMed ID: 36103513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear export and translation of circular repeat-containing intronic RNA in C9ORF72-ALS/FTD.
    Wang S; Latallo MJ; Zhang Z; Huang B; Bobrovnikov DG; Dong D; Livingston NM; Tjoeng W; Hayes LR; Rothstein JD; Ostrow LW; Wu B; Sun S
    Nat Commun; 2021 Aug; 12(1):4908. PubMed ID: 34389711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
    Zhang K; Grima JC; Rothstein JD; Lloyd TE
    Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C9orf72-associated arginine-rich dipeptide repeats induce RNA-dependent nuclear accumulation of Staufen in neurons.
    Kim ES; Chung CG; Park JH; Ko BS; Park SS; Kim YH; Cha IJ; Kim J; Ha CM; Kim HJ; Lee SB
    Hum Mol Genet; 2021 Jun; 30(12):1084-1100. PubMed ID: 33783499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins.
    Mizielinska S; Grönke S; Niccoli T; Ridler CE; Clayton EL; Devoy A; Moens T; Norona FE; Woollacott IOC; Pietrzyk J; Cleverley K; Nicoll AJ; Pickering-Brown S; Dols J; Cabecinha M; Hendrich O; Fratta P; Fisher EMC; Partridge L; Isaacs AM
    Science; 2014 Sep; 345(6201):1192-1194. PubMed ID: 25103406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A.
    Moens TG; Niccoli T; Wilson KM; Atilano ML; Birsa N; Gittings LM; Holbling BV; Dyson MC; Thoeng A; Neeves J; Glaria I; Yu L; Bussmann J; Storkebaum E; Pardo M; Choudhary JS; Fratta P; Partridge L; Isaacs AM
    Acta Neuropathol; 2019 Mar; 137(3):487-500. PubMed ID: 30604225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.